Digital Health Acquisition (DHAC) Short Interest Ratio & Short Volume

Short interest is the volume of Digital Health Acquisition shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 7,900 shares of DHAC short. 1.13% of Digital Health Acquisition's shares are currently sold short. Learn More on Digital Health Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.13% of Digital Health Acquisition's floating shares are currently sold short.

Digital Health Acquisition saw a increase in short interest in May. As of May 31st, there was short interest totaling 7,900 shares, an increase of 61.2% from the previous total of 4,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Digital Health Acquisition currently has issued a total of 3,604,000 shares. Some of Digital Health Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Digital Health Acquisition currently has a public float of 697,800 shares.

1.13% of Digital Health Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Digital Health Acquisition: Enzo Biochem, Inc. (0.97%), BioRestorative Therapies, Inc. (3.82%), Kindly MD, Inc. (4.18%), Mangoceuticals, Inc. (5.71%), Ontrak, Inc. (0.89%), BioNexus Gene Lab Corp. (26.50%), Vsee Health, Inc. (0.63%), Aclarion, Inc. (6.28%), ATI Physical Therapy, Inc. (5.31%), NewGenIvf Group Limited (10.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling DHAC is an investing strategy that aims to generate trading profit from Digital Health Acquisition as its price is falling. DHAC shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Digital Health Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DHAC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DHAC, twice per month. The most recent reporting period available is May, 31 2024.